TM
TMCWW
TMC the metals Co Inc.
$0.2600
+1.96%
$112.6M
No data for this timeframe.
Vol
Market Cap$112.6M
Cap SizeMicro Cap
Inst. Holders4 funds
Inst. Value$681.7K
Inst. Activity2 buys / 0 sells
SEC Reports4
Recent Activity
May 28, 2026
SEC
NOAA formally certified TMC USA's USA B exploration license application under the Deep Seabed Hard Mineral Resources Act
8-K — Impact 4/10
May 26, 2026
SEC
TMC the metals Co Inc. filed a DEFA14A supplement clarifying that brokers will NOT have discretionary authority to vote
DEFA14A — Impact 3/10
May 14, 2026
SEC
TMC reported Q1 2026 results: net loss of $20.6M ($0.05/share) vs $20.6M ($0.06/share) a year ago, with cash used in ope
8-K — Impact 5/10
Inst.
LMR Partners LLP — DOUBLED
1,990,824 shares ($2.6M)
Inst.
WOLVERINE ASSET MANAGEMENT LLC — DOUBLED
84,457 shares ($109.0K)
Latest Reports
NEUTRAL
8-K
4/10
NOAA formally certified TMC USA's USA B exploration license application under the Deep Seabed Hard Mineral Resources Act
May 28, 2026
NEUTRAL
DEFA14A
3/10
TMC the metals Co Inc. filed a DEFA14A supplement clarifying that brokers will NOT have discretionary authority to vote
May 26, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| LMR Partners LLP | $648.5K | DOUBLED |
| WOLVERINE ASSET MANAGEMENT LLC | $30.7K | DOUBLED |
| WELLS FARGO & COMPANY/MN | $2.4K | — |
| HRT FINANCIAL LP | $25.00 | TRIM |
4 institutional holders with $681.7K total value (2,175,688 shares) as of 2026-Q1. Top holders: LMR, WOLVERINE, WELLS.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | LMR Partners LLP | 1,994,782 | $648.5K | 95.1% | DOUBLED +4643.0% |
| 2 | WOLVERINE ASSET MANAGEMENT LLC | 94,541 | $30.7K | 4.5% | DOUBLED +253.1% |
| 3 | WELLS FARGO & COMPANY/MN | 7,500 | $2.4K | 0.4% | — |
| 4 | HRT FINANCIAL LP | 78,865 | $25.00 | 0.0% | TRIM -67.0% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| LMR Partners LLP | DOUBLED | 41,974 | 1,990,824 | +4643.0% | $2.6M | 2025-Q4 |
| WOLVERINE ASSET MANAGEMENT LLC | DOUBLED | 23,918 | 84,457 | +253.1% | $109.0K | 2025-Q4 |
| UBS Group AG | DOUBLED | 646 | 1,713 | +165.2% | $2.5K | 2025-Q2 |
| UBS Group AG | NEAR_EXIT | 8,569 | 646 | -92.5% | $143.00 | 2025-Q1 |
| WOLVERINE ASSET MANAGEMENT LLC | TRIM | 11,196 | 8,246 | -26.3% | $904.00 | 2024-Q4 |
| WOLVERINE ASSET MANAGEMENT LLC | DOUBLED | 4,314 | 11,196 | +159.5% | $922.00 | 2024-Q3 |
| HRT FINANCIAL LP | TRIM | 68,998 | 22,745 | -67.0% | $1.00 | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 4 neutral. Avg impact: 3.8/10.
NEUTRAL
8-K
4/10
NOAA formally certified TMC USA's USA B exploration license application under the Deep Seabed Hard M
May 28, 2026
NEUTRAL
DEFA14A
3/10
TMC the metals Co Inc. filed a DEFA14A supplement clarifying that brokers will NOT have discretionar
May 26, 2026
NEUTRAL
8-K
5/10
TMC reported Q1 2026 results: net loss of $20.6M ($0.05/share) vs $20.6M ($0.06/share) a year ago, w
May 14, 2026
NEUTRAL
DEFA14A
3/10
TMC the metals Co Inc. filed a DEFA14A proxy statement for its 2026 Annual Meeting of Shareholders,
Apr 17, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 0.0% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 0.0% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 0.0% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 0.0% | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
Recent Reddit Threads
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.